CCDC22 Monoclonal Antibody (OTI2E4), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Supplier:  OriGene TA811111

Catalog No. 50-168-3827

Description

CCDC22 is a recently identified coiled-coil domain-containing protein that has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. In rat, CCDC22 has been observed to localize in multiple regions of the brain, including the prefrontal and somatosensory cortex, dentate gyrus and thalamus, and in the ipsilateral motor neurons of the spinal cord after sciatic nerve transection suggesting that it may play a role in neuronal injury response. The human CCDC22 gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability (XLID).

Specifications

• Antigen: CCDC22
• Classification: Monoclonal
• Concentration: 1 mg/mL
• Formulation: PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
• Gene Accession No.: O60826
• Gene Symbols: CCDC22
• Immunogen: Full length human recombit protein of human CCDC22 produced in E.coli.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1

• Applications: Immunohistochemistry (Paraffin), Western Blot
• Clone: OTI2E4
• Conjugate: Unconjugated
• Gene: CCDC22
• Gene Alias: CXorf37, JM1, RTSC2
• Host Species: Mouse
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 28952
• Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
• Form: Liquid